Cargando…

Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth

INTRODUCTION: Recently, the pleiotropic benefits of incretin-based therapy have been reported. We have previously reported that Exendin–4, a glucagon-like peptide–1 (GLP–1) receptor agonist, attenuates prostate cancer growth. Metformin is known for its anti-cancer effect. Here, we examined the anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutsumi, Yoko, Nomiyama, Takashi, Kawanami, Takako, Hamaguchi, Yuriko, Terawaki, Yuichi, Tanaka, Tomoko, Murase, Kunitaka, Motonaga, Ryoko, Tanabe, Makito, Yanase, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595004/ https://www.ncbi.nlm.nih.gov/pubmed/26439622 http://dx.doi.org/10.1371/journal.pone.0139709

Ejemplares similares

Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
por: Terawaki, Yuichi, et al.
Publicado: (2014)

GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database
por: Tanabe, Makito, et al.
Publicado: (2015)

Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database
por: Tanabe, Makito, et al.
Publicado: (2016)

Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression
por: Shigeoka, Toru, et al.
Publicado: (2020)

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2015)

Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes
por: Muta, Yoshimi, et al.
Publicado: (2019)

Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet
por: Horikawa, Tsuyoshi, et al.
Publicado: (2020)

Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line
por: Fukuda, Takashi, et al.
Publicado: (2016)

Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives
por: Yanase, Tashihiko, et al.
Publicado: (2017)

SUN-026 Selective Androgen Receptor Modulator S42 Has Anabolic and Anti-Catabolic Effects on Cultured Myotubes
por: Muta, Yoshimi, et al.
Publicado: (2019)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2013)

Significance of Metformin Use in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2020)

Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3
por: Tsutsumi, Yasuo M, et al.
Publicado: (2014)

OR02-2 CX-4945 as a Potential Drug for Adrenocortical Carcinoma That Induces Multiple Exon-Skipping and Circular RNA of NR5A1
por: Tanaka, Tomoko, et al.
Publicado: (2019)

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5′ Splice Site
por: Ohe, Kenji, et al.
Publicado: (2018)

A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration
por: Ohkubo, Kumiko, et al.
Publicado: (2014)

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
por: Arakawa, Masayuki, et al.
Publicado: (2010)

SUN-144 High Prevalence of Diabetes in Patients with Primary Aldosteronism (PA) Associated with Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA
por: Akehi, Yuko, et al.
Publicado: (2019)

Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway
por: Yu, Hsin-Hsien, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021)

Development of a simple prediction model for adrenal crisis diagnosis
por: Katabami, Takuyuki, et al.
Publicado: (2020)

Exendin-4 Pretreatment Attenuates Kainic Acid-Induced Hippocampal Neuronal Death
por: Ahn, Yu-Jeong, et al.
Publicado: (2021)

Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson’s disease
por: Yu, Hai-Yang, et al.
Publicado: (2022)

Exendin-4 for Parkinson's disease
por: Esparza-Salazar, Felipe de Jesús, et al.
Publicado: (2021)

Isolation of epizootic hemorrhagic disease virus serotype 7 from cattle showing fever in Japan in 2016 and improvement of a reverse transcription-polymerase chain reaction assay to detect epizootic hemorrhagic disease virus
por: YAMAMOTO, Kunitaka, et al.
Publicado: (2021)

SAT-369 Proposal of Optimal Cutoff value for Serum Cortisol after an Overnight 1-mg Dexamethasone Suppression Test - Results from Multicenter Collaborative Research in Japan.
por: Tanabe, Makito, et al.
Publicado: (2019)

ODP045 Implantation of Steroidogenic Cells Derived from Human Adipose-derived Stem Cells Extends Survival in a Mouse Model of Adrenal Insufficiency
por: Tanaka, Tomoko, et al.
Publicado: (2022)

Suppression of ROS Production by Exendin-4 in PSC Attenuates the High Glucose-Induced Islet Fibrosis
por: Kim, Ji-Won, et al.
Publicado: (2016)

Exendin-4 attenuates atherosclerosis progression via controlling hematopoietic stem/progenitor cell proliferation
por: Yan, Cen, et al.
Publicado: (2023)

Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013)

Exendin-4 antagonizes Aβ1-42-induced attenuation of spatial learning and memory ability
por: Wang, Xiaohui, et al.
Publicado: (2016)

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
por: Tate, Mitchel, et al.
Publicado: (2015)

JNK3 Is Required for the Cytoprotective Effect of Exendin 4
por: Ezanno, Hélène, et al.
Publicado: (2014)

Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction
por: Le, Ying, et al.
Publicado: (2016)

Exendin-4 regulates pancreatic ABCA1 transcription via CaMKK/CaMKIV pathway
por: Li, Junhua, et al.
Publicado: (2010)

Expansion of transplanted islets in mice by co-transplantation with adipose tissue-derived mesenchymal stem cells
por: Tanaka, Tomoko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q7plsj5kqlkde4c28f74pa1kv8